
UFP Industries (UFPI) reported Q2 2025 earnings of $1.70 per share, missing the Zacks Consensus Estimate of $1.95, and revenues of $1.84 billion, which also fell short of expectations. This marks the fourth consecutive quarter the company has missed EPS estimates and the third revenue miss in four quarters, contributing to its 6.9% year-to-date stock decline against an S&P 500 gain. Despite a pre-report Zacks Rank #2 (Buy) based on favorable estimate revisions, the stock's immediate outlook will largely depend on management's commentary during the earnings call, especially given the Building Products - Wood industry's current weak ranking.
UFP Industries reported a significant miss for its June 2025 quarter, with earnings per share of $1.70 falling 12.82% short of the $1.95 consensus estimate. This marks the fourth consecutive quarter the company has failed to meet EPS expectations. Revenues of $1.84 billion also missed forecasts and represented a decline from the $1.9 billion reported in the prior-year period. This persistent underperformance has contributed to the stock's 6.9% year-to-date loss, which stands in stark contrast to the S&P 500's 8.6% gain. A critical point of uncertainty for investors is the conflict between these negative results and the stock's pre-earnings Zacks Rank #2 (Buy), which was based on favorable estimate revisions. The company's weak performance is amplified by a challenging industry environment, with the Zacks Building Products - Wood industry ranking in the bottom 12% of sectors. The outlook for peer Louisiana-Pacific (LPX), which is expected to report a 53.6% year-over-year earnings decline, further underscores sector-wide headwinds. Consequently, management's commentary on the upcoming earnings call will be paramount in determining the stock's near-term direction and whether the recent positive estimate revisions can be justified.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
mixed
Sentiment Score
-0.10
Ticker Sentiment